Apartment search is moving out of Google and into AI, faster than most landlords seem to realize. ChatGPT is now handling billions of queries a day, and new multifamily research suggests renters are already using AI tools to help decide where to live.

That shift matters because AI does not work like traditional search. Instead of sending renters through pages of links, it often gives them a direct answer, and many of those searches end without a click at all. That means the model’s description of a property may matter as much as the property’s website.

For multifamily operators, this raises the bar. In an AI-driven search environment, visibility depends less on paid placement and more on whether a community has a real reputation worth repeating. The apartment marketers who adapt first may find that AI is not just changing search traffic, but reshaping who wins the lease.

A new report from Redfin suggests that allowing sellers to test the market before officially listing their homes could increase housing supply by as much as 6 to 12 percent. The idea is simple. If sellers can gauge demand through “coming soon” or private listings, they may feel more confident about pricing and timing, which could push more homeowners to list. Redfin argues that uncertainty around pricing is one of the biggest reasons people stay on the sidelines, and pre marketing helps reduce that friction.

There is some logic behind that. Redfin’s own analysis shows that pre-marketed homes are less likely to undergo price cuts and spend less time on the market. That can lead to better outcomes for sellers and more stable pricing signals for buyers. It also fits into a broader push by brokerages to give sellers more control over how their homes are introduced to the market, especially as the traditional MLS model faces more competition from private listing networks.

The study does have a notable conflict of interest. Redfin recently entered into a partnership with Compass that will push a large volume of pre-market listings onto its platform, potentially adding hundreds of thousands of homes. Those listings can appear without traditional signals like days on market or price history, which are key data points buyers use to evaluate a property. That creates a clear incentive for Redfin to highlight the benefits of pre-marketing, even as the practice remains controversial across the industry.

The result is a growing divide over what pre-listing really does to the market. It may bring more sellers off the sidelines and increase inventory at the margin. But it can also limit transparency and shift power toward platforms and brokerages that control early access to listings. If more of the housing market moves into this pre-market phase, it could change not just how homes are sold, but who controls the information that buyers rely on.

TerraPower, the nuclear science company founded by Bill Gates, plans to build a $450 million radioisotope manufacturing plant at the Bellwether District in South Philadelphia. The 250,000-square-foot build-to-suit facility will be operated by TerraPower Isotopes, the company’s nuclear medicine division, and will focus on producing actinium-225, a rare isotope used in targeted cancer therapies. Pennsylvania is supporting the project with $10 million in grants, and the facility is expected to create 225 full-time jobs over the next three years, though no construction start date has been announced.

The company said it evaluated more than 350 sites and made 49 visits across eight U.S. metro areas before choosing Bellwether, a 1,300-acre redevelopment of the former Philadelphia Energy Solutions refinery. The site’s appeal appears to be tied to both infrastructure and location, with easy access to highways, rail, maritime shipping, Center City, the airport, and the port. TerraPower framed the project as a response to growing demand for actinium-225, which is increasingly important in precision oncology because radioisotopes can be attached to molecules that seek out and destroy cancer cells.

The plant also reflects how TerraPower is expanding well beyond the advanced reactor work for which it is best known. While the company is building its Natrium reactor project in Wyoming and pursuing larger clean energy ambitions, this move shows it is also trying to establish a meaningful role in nuclear medicine and isotope supply chains. In that sense, the Philadelphia project is not just another manufacturing announcement. It is part of a broader effort to position nuclear technology as relevant not only to power generation, but also to healthcare, pharmaceuticals, and other high-value industrial uses.

The larger significance is that this points to a bigger shift in how the next generation of industrial development is being defined. Old heavy-industry sites are being remade for advanced manufacturing tied to medicine, clean energy, and strategic domestic supply chains. At the same time, products once viewed as highly specialized, like medical isotopes, are becoming central to major growth industries because they sit at the intersection of healthcare innovation, national competitiveness, and resilient production capacity. TerraPower’s investment is a sign that the future of industrial real estate may be shaped less by traditional factory demand and more by companies building highly technical facilities for sectors with long-term strategic importance.

Propmodo Daily is written and edited by Franco Faraudo with contributions from readers like you and the Propmodo team.

📧 Forward it to a friend and suggest they check it out.

🔗 Share a link to this post on social media.

🗣 Have ideas for future topics (or just want to say hello)? Share your feedback and tips at [email protected] or connect with us on X through @propmodo.

✅ Not subscribed yet? Sign up for this newsletter here.

📫 Please add our newsletter email, [email protected], to your contacts to make sure you don’t miss any updates.

Enjoy reading about trends and innovation in commercial real estate? Subscribe to Propmodo.com for unrestricted access to reliable, data-driven journalism and exclusive insights available only to subscribers.